Skip to Content

Flu Vaccine Webcast

HHS Science Seminar for Media: Advances in Influenza Vaccine Technologies

(BUSINESS WIRE)--Dec 11, 2009 - The Department of Health and Human Services (HHS) will host a three-hour educational program for the media to learn more about ongoing government research efforts to develop and apply new technologies in the making of seasonal and pandemic influenza vaccines.



  Francis Collins, M.D., Ph.D., Director, National Institutes of Health (NIH)


    Bruce Gellin, M.D., M.P.H., Director, National Vaccine Program Office, HHS


    Anthony Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases, NIH


    Gary Nabel, M.D., Ph.D., Director, Vaccine Research Center, NIAID/NIH


    Carole Heilman, Ph.D., Director, Division of Microbiology and Infectious Diseases, NIAID/NIH


    Robin Robinson, Ph.D., Director, Biomedical Advanced Research & Development Authority/ HHS


    Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health, FDA (Acting)


    Other HHS officials TBD




  Science Seminar for Media: Advances in Influenza Vaccine Technologies


  Friday, December 11, 2009, 9:00 a.m. to 12:00 noon (EST)


  View on the Web:; questions may be submitted live during the Webcast via email at


    Attend in Person*: Wilson Hall, Building 1, National Institutes of Health, 9000 Rockville Pike, Bethesda, Md.


*For those interested in attending this seminar in person, please contact the HHS Press Office at 202-690-6343 or by email at for specific logistics information and pre-registration. In person attendees are encouraged to take Metrorail to the NIH campus, as visitor parking is limited. Metrorail users should take the Red Line and exit the system at the Medical Center station, which is located directly on the NIH campus.


Contact: HHS Press Office


Posted: December 2009